Table 3.
Antimicrobial resistance rate (%) of Uu and Mh co‐infection in patients
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| Case (%) | Case (%) | Case (%) | Case (%) | Case (%) | |
| TET | 11 (22.4) | 30 (28.6) | 32 (23.0) | 46 (28.6) | 119 (24.1) |
| LEV | 28 (57.1) | 56 (53.3) | 77 (55.4) | 102 (63.4) | 295 (59.8) |
| ERY | 49 (100) | 102 (97.1) | 136 (97.8) | 154 (95.7) | 490 (99.4) |
| JOS | 0 (0.0) | 8 (7.6) | 5 (3.6) | 2 (1.2) | 5 (1.0) |
| DOX | 3 (6.1) | 6 (5.7) | 9 (6.5) | 11 (6.8) | 34 (6.9) |
| CIP | 42 (85.7) | 95 (90.5) | 127 (91.4) | 152 (94.4) | 452 (91.7) |
| OFX | 25 (51.0) | 59 (56.2) | 73 (52.5) | 98 (60.9) | 260 (52.7) |
| MIN | 2 (4.1) | 3 (2.9) | 11 (7.9) | 12 (7.5) | 38 (7.7) |
| ROX | 48 (98.0) | 99 (94.3) | 131 (94.2) | 150 (93.2) | 462 (93.7) |
| AZM | 48 (98.0) | 97 (92.4) | 127 (91.4) | 148 (91.9) | 456 (92.5) |
| CLR | 48 (98.0) | 98 (93.3) | 129 (92.8) | 148 (91.9) | 455 (92.3) |
| SPA | 27 (55.1) | 67 (63.8) | 89 (64.0) | 110 (68.3) | 237 (48.1) |
| n | 49 | 105 | 139 | 161 | 493 |
Abbreviations: AZM, azithromycin; CIP, ciprofloxacin; CLR, clarithromycin; DOX, doxycycline; ERY, erythromycin; JOS, josamycin; LEV, levofloxacin; Mh, Mycoplasma hominis; MIN, minocycline; OFX, ofloxacin; ROX, roxithromycin; SPA, sparfloxacin; TET, tetracycline; Uu, Ureaplasma urealyticum.